TH1902 in Patients With Advanced Solid Tumors

TH1902 in Patients With Advanced Solid Tumors
Conditions:   Solid Tumor;   TNBC – Triple-Negative Breast Cancer;   Hormone Receptor-positive Breast Cancer;   Epithelial Ovarian Cancer;   Endometrial Cancer;   Cutaneous Melanoma;   Thyroid Cancer;   Small-cell Lung Cancer;   Prostate Cancer
Intervention:   Drug: TH1902
Sponsors:   Theratechnologies;   PPD

Source: View full study details on

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

July 1, 2022Comments | Endocrinology Clinical Trials | Endocrinology Studies | US National Library of Medicine